Paul Stockdale
Vermögen: 15 964 $ am 31.05.2026
Vermögen: 15 964 $ am 31.05.2026
Paul Stockdale currently works at Oxford BioDynamics Plc, as Chief Financial Officer & Executive Director.
Mr. Stockdale also formerly worked at e-Therapeutics Plc, as Financial Controller from 2012 to 2017 and Deloitte & Touche LLP UK, as Senior Manager from 1996 to 2004.
Mr. Stockdale received his graduate degree from the University of Cambridge.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.11.2025 | 6’411’252 ( 0.15% ) | 15 964 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD BIODYNAMICS PLC | Finanzdirektor/CFO | 15.09.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| E-THERAPEUTICS PLC | Comptroller/Controller/Auditor | 01.09.2017 |
Deloitte & Touche LLP UK
Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Provides financial advisory and accounting services | Corporate Officer/Principal | 01.01.2004 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
e-Therapeutics Plc
e-Therapeutics Plc BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deloitte & Touche LLP UK
Deloitte & Touche LLP UK Miscellaneous Commercial ServicesCommercial Services Provides financial advisory and accounting services | Commercial Services |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen